Portfolio Holdings Detail for ISIN IE00B3VWM098
Stock Name / Fund iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer Blackrock
Entity holding fund iShares VII Public Limited Company
Entity Type Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI 549300Q7FFITMZ2PFZ28
ETF Ticker CUS1(GBX) LSE
ETF Ticker CUSS(USD) LSE
ETF Ticker SXRG(EUR) F
ETF Ticker CSUSS.MI(EUR) CXE
ETF Ticker CSUSSz(USD) CXE
ETF Ticker CUSS.LS(USD) CXE
ETF Ticker CSUSS(EUR) ETF Plus
ETF Ticker CUS1.L(GBP) LSE
ETF Ticker CUSS.L(GBP) LSE

Holdings detail for IART

Stock Name	Integra LifeSciences Holdings
Ticker	IART(USD) NASDAQ
TYPE	Common Stock
Country	USA
ISIN	US4579852082
LEI	WB7IJCYY8YFTENS4O147

Show aggregate IART holdings

News associated with IART

Integra LifeSciences Holdings Corporation (NASDAQ:IART) Receives $18.63 Consensus Target Price from Analysts: Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART – Get Free Report) have received an average recommendation of “Reduce” from the nine ratings firms that are covering the firm, Marketbeat Ratings reports. Four research analysts have rated the stock with a sell rating, three have issued a hold rating and two have issued a buy rating […] - 2025-08-06 02:14:54
Integra LifeSciences (NASDAQ:IART) Shares Up 8.8% on Better-Than-Expected Earnings: Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART – Get Free Report) traded up 8.8% during trading on Thursday following a better than expected earnings announcement. The company traded as high as $14.07 and last traded at $13.46. 362,656 shares were traded during trading, a decline of 62% from the average session volume of 964,277 shares. […] - 2025-08-01 03:10:52
Victory Capital Management Inc. Acquires 135,308 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART): Victory Capital Management Inc. raised its holdings in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) by 1,067.6% during the 1st quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 147,982 shares of the life sciences company’s stock after buying an additional 135,308 shares during the quarter. […] - 2025-07-28 05:16:52
Bank of New York Mellon Corp Sells 30,447 Shares of Integra LifeSciences Holdings Corporation (NASDAQ:IART): Bank of New York Mellon Corp decreased its stake in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) by 6.5% in the 1st quarter, Holdings Channel.com reports. The fund owned 437,515 shares of the life sciences company’s stock after selling 30,447 shares during the quarter. Bank of New York Mellon Corp’s holdings in Integra LifeSciences […] - 2025-07-22 06:22:52
11,425 Shares in Integra LifeSciences Holdings Corporation (NASDAQ:IART) Acquired by Wealth Enhancement Advisory Services LLC: Wealth Enhancement Advisory Services LLC acquired a new position in Integra LifeSciences Holdings Corporation (NASDAQ:IART – Free Report) in the 1st quarter, Holdings Channel reports. The firm acquired 11,425 shares of the life sciences company’s stock, valued at approximately $251,000. Other hedge funds also recently added to or reduced their stakes in the company. Assenagon […] - 2025-07-10 04:14:55
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $18.63 Consensus PT from Analysts: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have been assigned a consensus rating of “Reduce” from the nine brokerages that are currently covering the company, Marketbeat Ratings reports. Four investment analysts have rated the stock with a sell rating, three have assigned a hold rating and two have issued a buy […] - 2025-06-17 02:49:03
Analyzing Integra LifeSciences (NASDAQ:IART) and Arch Therapeutics (OTCMKTS:ARTH): Arch Therapeutics (OTCMKTS:ARTH – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their valuation, profitability, institutional ownership, earnings, dividends, risk and analyst recommendations. Volatility and Risk Arch Therapeutics has a […] - 2025-06-16 02:40:44
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Squarepoint Ops LLC: Squarepoint Ops LLC decreased its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 71.8% during the fourth quarter, Holdings Channel.com reports. The firm owned 25,285 shares of the life sciences company’s stock after selling 64,458 shares during the period. Squarepoint Ops LLC’s holdings in Integra LifeSciences were worth $573,000 as […] - 2025-06-04 05:48:48
75,900 Shares in Integra LifeSciences Holdings Co. (NASDAQ:IART) Bought by Universal Beteiligungs und Servicegesellschaft mbH: Universal Beteiligungs und Servicegesellschaft mbH purchased a new position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) during the 4th quarter, Holdings Channel.com reports. The firm purchased 75,900 shares of the life sciences company’s stock, valued at approximately $1,721,000. Other hedge funds and other institutional investors have also recently bought and sold […] - 2025-06-03 05:34:56
BNP Paribas Financial Markets Has $333,000 Position in Integra LifeSciences Holdings Co. (NASDAQ:IART): BNP Paribas Financial Markets cut its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 86.9% during the fourth quarter, according to its most recent disclosure with the SEC. The institutional investor owned 14,690 shares of the life sciences company’s stock after selling 97,085 shares during the period. BNP Paribas Financial […] - 2025-05-27 06:12:44
MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. Buys 1,437 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.9% in the 4th quarter, Holdings Channel reports. The institutional investor owned 38,466 shares of the life sciences company’s stock after buying an additional 1,437 shares during the quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS […] - 2025-05-27 04:47:03
Financial Review: Integra LifeSciences (NASDAQ:IART) and Vivos (OTCMKTS:RDGL): Integra LifeSciences (NASDAQ:IART – Get Free Report) and Vivos (OTCMKTS:RDGL – Get Free Report) are both small-cap medical companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, analyst recommendations, valuation, profitability, dividends, institutional ownership and earnings. Profitability This table compares Integra LifeSciences and Vivos’ […] - 2025-05-26 02:20:55
Brokerages Set Integra LifeSciences Holdings Co. (NASDAQ:IART) Price Target at $18.63: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) have been given an average recommendation of “Reduce” by the nine analysts that are currently covering the company, MarketBeat Ratings reports. Four research analysts have rated the stock with a sell recommendation, three have assigned a hold recommendation and two have issued a buy […] - 2025-05-23 02:48:54
Integra LifeSciences (NASDAQ:IART) Hits New 12-Month Low Following Weak Earnings: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) hit a new 52-week low during mid-day trading on Tuesday after the company announced weaker than expected quarterly earnings. The company traded as low as $11.60 and last traded at $13.28, with a volume of 7492449 shares trading hands. The stock had previously closed […] - 2025-05-07 03:10:42
Head to Head Review: Integra LifeSciences (NASDAQ:IART) & Venus Concept (NASDAQ:VERO): Venus Concept (NASDAQ:VERO – Get Free Report) and Integra LifeSciences (NASDAQ:IART – Get Free Report) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, risk, dividends, earnings, valuation, profitability and analyst recommendations. Analyst Recommendations This is a breakdown of […] - 2025-05-06 02:46:55
Integra LifeSciences (NASDAQ:IART) Shares Gap Down Following Weak Earnings: Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) gapped down before the market opened on Monday following a dissappointing earnings announcement. The stock had previously closed at $16.85, but opened at $14.73. Integra LifeSciences shares last traded at $11.88, with a volume of 1,189,112 shares traded. The life sciences company reported $0.41 […] - 2025-05-06 02:10:50
Integra LifeSciences Holdings Co. (NASDAQ:IART) Receives $22.71 Consensus PT from Analysts: Integra LifeSciences Holdings Co. (NASDAQ:IART – Get Free Report) has earned an average recommendation of “Reduce” from the nine ratings firms that are covering the company, Marketbeat reports. Three equities research analysts have rated the stock with a sell rating, four have issued a hold rating and two have assigned a buy rating to the […] - 2025-04-28 02:24:43
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Purchased by Sterling Capital Management LLC: Sterling Capital Management LLC boosted its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 821.7% in the 4th quarter, according to its most recent filing with the SEC. The fund owned 2,166 shares of the life sciences company’s stock after purchasing an additional 1,931 shares during the period. Sterling Capital Management LLC’s […] - 2025-04-24 05:46:54
Legal & General Group Plc Has $4.91 Million Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART): Legal & General Group Plc lessened its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 6.9% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The firm owned 216,507 shares of the life sciences company’s stock after selling 16,109 shares during the quarter. Legal & […] - 2025-04-22 04:44:49
Sei Investments Co. Decreases Stock Position in Integra LifeSciences Holdings Co. (NASDAQ:IART): Sei Investments Co. trimmed its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 19.0% in the 4th quarter, Holdings Channel.com reports. The institutional investor owned 18,953 shares of the life sciences company’s stock after selling 4,448 shares during the period. Sei Investments Co.’s holdings in Integra LifeSciences were worth $430,000 at the […] - 2025-04-10 04:24:49
Integra LifeSciences Holdings Co. (NASDAQ:IART) Shares Sold by Vanguard Group Inc.: Vanguard Group Inc. trimmed its holdings in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 2.1% in the fourth quarter, HoldingsChannel reports. The firm owned 7,580,967 shares of the life sciences company’s stock after selling 162,961 shares during the period. Vanguard Group Inc. owned approximately 0.10% of Integra LifeSciences worth $171,936,000 at […] - 2025-04-07 04:41:00
Integra LifeSciences (NASDAQ:IART) Raised to Buy at Argus: Integra LifeSciences (NASDAQ:IART – Get Free Report) was upgraded by equities research analysts at Argus from a “hold” rating to a “buy” rating in a report released on Monday, MarketBeat Ratings reports. Separately, Morgan Stanley assumed coverage on shares of Integra LifeSciences in a research report on Monday, December 2nd. They issued an “underweight” rating […] - 2025-04-02 03:12:48
Quantbot Technologies LP Has $179,000 Stock Holdings in Integra LifeSciences Holdings Co. (NASDAQ:IART): Quantbot Technologies LP lowered its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 89.1% during the fourth quarter, HoldingsChannel.com reports. The firm owned 7,881 shares of the life sciences company’s stock after selling 64,470 shares during the period. Quantbot Technologies LP’s holdings in Integra LifeSciences were worth $179,000 at the end of […] - 2025-03-31 04:39:00
Intech Investment Management LLC Acquires 11,174 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): Intech Investment Management LLC raised its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 86.4% during the fourth quarter, HoldingsChannel.com reports. The institutional investor owned 24,113 shares of the life sciences company’s stock after acquiring an additional 11,174 shares during the period. Intech Investment Management LLC’s holdings in Integra LifeSciences were worth […] - 2025-03-25 07:08:55
PNC Financial Services Group Inc. Grows Stake in Integra LifeSciences Holdings Co. (NASDAQ:IART): PNC Financial Services Group Inc. lifted its stake in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 33.6% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor owned 19,755 shares of the life sciences company’s stock after purchasing an additional […] - 2025-03-20 05:57:04
Integra LifeSciences Holdings Co. (NASDAQ:IART) Holdings Lowered by Bank of New York Mellon Corp: Bank of New York Mellon Corp cut its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.3% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 467,962 shares of the life sciences company’s stock after selling 15,830 shares […] - 2025-03-14 05:05:06
Amalgamated Bank Sells 478 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): Amalgamated Bank reduced its stake in Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 2.4% during the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 19,394 shares of the life sciences company’s stock after selling 478 shares during the quarter. Amalgamated Bank’s holdings […] - 2025-03-05 08:26:53
Yousif Capital Management LLC Sells 906 Shares of Integra LifeSciences Holdings Co. (NASDAQ:IART): Yousif Capital Management LLC decreased its position in shares of Integra LifeSciences Holdings Co. (NASDAQ:IART – Free Report) by 3.4% in the 4th quarter, HoldingsChannel reports. The firm owned 25,762 shares of the life sciences company’s stock after selling 906 shares during the quarter. Yousif Capital Management LLC’s holdings in Integra LifeSciences were worth $584,000 […] - 2025-02-17 06:42:58

iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc IART holdings

Date	Number of IART Shares Held	Base Market Value of IART Shares	Local Market Value of IART Shares	Change in IART Shares Held	Change in IART Base Value	Current Price per IART Share Held	Previous Price per IART Share Held
2025-09-29 (Monday)	35,552	USD 484,574	USD 484,574
2025-09-26 (Friday)	35,552	USD 469,286	USD 469,286
2025-09-25 (Thursday)	35,552	USD 468,575	USD 468,575	0	USD -25,953	USD 13.18	USD 13.91
2025-09-24 (Wednesday)	35,552	USD 494,528	USD 494,528
2025-09-17 (Wednesday)	35,322	USD 522,766	USD 522,766	0	USD -1,059	USD 14.8	USD 14.83
2025-09-16 (Tuesday)	35,322	USD 523,825	USD 523,825
2025-09-12 (Friday)	35,092	USD 528,486	USD 528,486

Share price and value of shares held is calculated on the adjusted close price of each day (row). Changes between days reflect the gain/loss of the portfolio as a result of changes in the adjusted close price and changes in the holdings

Share Trades of IART by Blackrock for IE00B3VWM098

Show aggregate share trades of IART

Date Action Quantity Market High Market Low Likely Trade Price Likely Trade Value (Profit/Loss) Average Price previous trades
2025-09-11 BUY 460 15.470* 18.57
2025-08-21 SELL -163 13.680* 18.60 Profit of 3,032 on sale
2025-07-31 BUY 489 13.140* 18.66
2025-06-30 SELL -326 12.270* 19.45 Profit of 6,340 on sale
2025-06-25 SELL -163 11.870* 19.60 Profit of 3,195 on sale
2025-06-20 SELL -326 11.600* 19.77 Profit of 6,445 on sale
2025-05-23 BUY 163 12.300* 20.94
2025-05-19 SELL -163 13.550* 21.21 Profit of 3,458 on sale
2025-05-15 SELL -489 13.010* 21.35 Profit of 10,441 on sale
2025-05-12 SELL -163 13.670* 21.57 Profit of 3,516 on sale
2025-05-09 SELL -163 12.250* 21.65 Profit of 3,529 on sale
2025-04-30 SELL -163 16.390* 22.14 Profit of 3,609 on sale
2025-04-24 SELL -326 16.700* 22.35 Profit of 7,287 on sale
2025-04-17 SELL -163 15.830* 22.70 Profit of 3,701 on sale
2025-04-15 SELL -489 16.080* 22.85 Profit of 11,175 on sale
2025-04-14 SELL -489 16.730* 22.92 Profit of 11,207 on sale
2025-04-09 SELL -652 19.190* 23.09 Profit of 15,056 on sale
2025-04-07 SELL -1,141 19.580* 23.19 Profit of 26,460 on sale
2025-04-04 SELL -1,630 19.570* 23.23 Profit of 37,870 on sale
2025-03-31 BUY 163 21.990* 23.29
2025-03-19 SELL -326 22.820* 23.39 Profit of 7,626 on sale
2025-03-14 SELL -978 22.350* 23.42 Profit of 22,907 on sale
2025-03-13 SELL -328 22.270* 23.44 Profit of 7,688 on sale
2025-03-12 SELL -5,576 22.240* 23.46 Profit of 130,792 on sale
2025-03-07 SELL -328 23.000* 23.47 Profit of 7,698 on sale
2025-03-06 SELL -492 22.030* 23.49 Profit of 11,557 on sale
2025-03-03 SELL -164 22.480* 23.56 Profit of 3,864 on sale
2025-02-28 SELL -984 23.210* 23.56 Profit of 23,187 on sale
2025-02-26 SELL -164 23.600* 23.57 Profit of 3,866 on sale
2025-02-25 SELL -492 24.720* 23.55 Profit of 11,588 on sale
2025-02-18 BUY 820 23.320* 23.68
2025-02-13 BUY 164 24.260* 23.64
2025-02-12 BUY 164 24.080* 23.64
2025-02-11 BUY 492 25.680* 23.59
2025-02-06 BUY 1,476 26.020* 23.46
2025-01-27 BUY 164 26.370* 22.87
2024-12-30 BUY 818 22.470* 22.70
2024-12-06 BUY 652 24.100* 22.55
2024-12-05 BUY 163 23.860* 22.50
2024-12-04 BUY 815 24.110* 22.45
2024-11-29 BUY 815 24.580* 22.19
2024-11-27 BUY 652 24.540* 21.98
2024-11-26 BUY 163 23.700* 21.91
2024-11-25 SELL -35,361 24.240* 21.79 Profit of 770,685 on sale
2024-11-21 BUY 1,355 23.000* 21.64
2024-11-20 BUY 813 22.930* 21.57
2024-11-18 BUY 3,240 22.490* 21.43
2024-11-12 BUY 2,160 24.810* 21.20
2024-11-08 BUY 1,350 24.780* 20.94
2024-11-07 BUY 4,050 25.510* 20.59
2024-11-06 BUY 540 26.700* 20.08
2024-10-31 BUY 270 18.760* 19.24
Market high and low price is on the date.

Date	Action	Quantity	Likely Trade Price	Average Price previous trades
2025-09-11	BUY	460	15.470*	18.57
2025-08-21	SELL	-163	13.680*	18.60 Profit of 3,032 on sale
2025-07-31	BUY	489	13.140*	18.66
2025-06-30	SELL	-326	12.270*	19.45 Profit of 6,340 on sale
2025-06-25	SELL	-163	11.870*	19.60 Profit of 3,195 on sale
2025-06-20	SELL	-326	11.600*	19.77 Profit of 6,445 on sale
2025-05-23	BUY	163	12.300*	20.94
2025-05-19	SELL	-163	13.550*	21.21 Profit of 3,458 on sale
2025-05-15	SELL	-489	13.010*	21.35 Profit of 10,441 on sale
2025-05-12	SELL	-163	13.670*	21.57 Profit of 3,516 on sale
2025-05-09	SELL	-163	12.250*	21.65 Profit of 3,529 on sale
2025-04-30	SELL	-163	16.390*	22.14 Profit of 3,609 on sale
2025-04-24	SELL	-326	16.700*	22.35 Profit of 7,287 on sale
2025-04-17	SELL	-163	15.830*	22.70 Profit of 3,701 on sale
2025-04-15	SELL	-489	16.080*	22.85 Profit of 11,175 on sale
2025-04-14	SELL	-489	16.730*	22.92 Profit of 11,207 on sale
2025-04-09	SELL	-652	19.190*	23.09 Profit of 15,056 on sale
2025-04-07	SELL	-1,141	19.580*	23.19 Profit of 26,460 on sale
2025-04-04	SELL	-1,630	19.570*	23.23 Profit of 37,870 on sale
2025-03-31	BUY	163	21.990*	23.29
2025-03-19	SELL	-326	22.820*	23.39 Profit of 7,626 on sale
2025-03-14	SELL	-978	22.350*	23.42 Profit of 22,907 on sale
2025-03-13	SELL	-328	22.270*	23.44 Profit of 7,688 on sale
2025-03-12	SELL	-5,576	22.240*	23.46 Profit of 130,792 on sale
2025-03-07	SELL	-328	23.000*	23.47 Profit of 7,698 on sale
2025-03-06	SELL	-492	22.030*	23.49 Profit of 11,557 on sale
2025-03-03	SELL	-164	22.480*	23.56 Profit of 3,864 on sale
2025-02-28	SELL	-984	23.210*	23.56 Profit of 23,187 on sale
2025-02-26	SELL	-164	23.600*	23.57 Profit of 3,866 on sale
2025-02-25	SELL	-492	24.720*	23.55 Profit of 11,588 on sale
2025-02-18	BUY	820	23.320*	23.68
2025-02-13	BUY	164	24.260*	23.64
2025-02-12	BUY	164	24.080*	23.64
2025-02-11	BUY	492	25.680*	23.59
2025-02-06	BUY	1,476	26.020*	23.46
2025-01-27	BUY	164	26.370*	22.87
2024-12-30	BUY	818	22.470*	22.70
2024-12-06	BUY	652	24.100*	22.55
2024-12-05	BUY	163	23.860*	22.50
2024-12-04	BUY	815	24.110*	22.45
2024-11-29	BUY	815	24.580*	22.19
2024-11-27	BUY	652	24.540*	21.98
2024-11-26	BUY	163	23.700*	21.91
2024-11-25	SELL	-35,361	24.240*	21.79 Profit of 770,685 on sale
2024-11-21	BUY	1,355	23.000*	21.64
2024-11-20	BUY	813	22.930*	21.57
2024-11-18	BUY	3,240	22.490*	21.43
2024-11-12	BUY	2,160	24.810*	21.20
2024-11-08	BUY	1,350	24.780*	20.94
2024-11-07	BUY	4,050	25.510*	20.59
2024-11-06	BUY	540	26.700*	20.08
2024-10-31	BUY	270	18.760*	19.24

* (if shown) = market close price used not a projected price. This is used when we do not have market data available to calculate a projection

The likely trade price/value is our estimate on the likely price the trade took place at and is not the actual trade price. The likely LOSS/GAIN is our estimate. Where a profit/loss value is shown in the Likely Trade Value column, this is derived from matching trades between periods eg the most recent previous BUY is matched with the SELL for the same number of shares and the difference between the likely BUY price and likely SELL price is calculated. Where a profit or loss is shown in the Average Price of Previous Trades column, this is dervied using the likely trade price compared to the average of previous trades based on adjusted close

Shorting History of IART

Date	Shorted Volume	Short Exempt Volume	Total Shares Traded	% Shorted
2025-09-19	200,860	0	342,324	58.7%
2025-09-18	245,523	0	426,036	57.6%
2025-09-17	219,298	0	308,535	71.1%
2025-09-16	189,736	0	339,123	55.9%
2025-09-15	311,405	0	512,195	60.8%
2025-09-12	205,909	0	320,823	64.2%
2025-09-11	350,439	0	718,800	48.8%
2025-09-10	247,943	0	396,708	62.5%
2025-09-09	260,941	0	485,210	53.8%
2025-09-08	306,988	528	453,325	67.7%
2025-09-05	346,937	0	460,014	75.4%
2025-09-04	398,359	0	759,826	52.4%
2025-09-03	485,867	0	778,196	62.4%
2025-09-02	231,976	0	373,414	62.1%
2025-08-29	417,210	981	707,670	59.0%
2025-08-28	323,733	0	583,378	55.5%
2025-08-27	557,498	807	1,292,647	43.1%
2025-08-26	315,944	0	528,778	59.7%
2025-08-25	317,205	0	482,389	65.8%
2025-08-22	382,724	0	717,891	53.3%
2025-08-21	178,737	0	284,394	62.8%
2025-08-20	341,582	31	691,272	49.4%
2025-08-19	368,719	0	685,728	53.8%
2025-08-18	371,715	0	701,232	53.0%
2025-08-15	327,206	0	620,445	52.7%
2025-08-14	241,966	0	473,349	51.1%
2025-08-13	265,549	526	710,399	37.4%
2025-08-12	269,644	0	810,623	33.3%
2025-08-11	306,600	0	800,147	38.3%
2025-08-08	362,062	300	898,715	40.3%
2025-08-07	382,300	0	998,598	38.3%
2025-08-06	441,392	53	927,921	47.6%
2025-08-05	491,034	0	872,429	56.3%
2025-08-04	313,621	66,725	657,282	47.7%
2025-08-01	645,719	40,049	960,271	67.2%
2025-07-31	937,686	0	1,264,837	74.1%
2025-07-30	268,419	0	456,370	58.8%
2025-07-29	234,719	0	447,928	52.4%
2025-07-28	285,598	0	597,581	47.8%
2025-07-25	215,394	110	504,276	42.7%
2025-07-24	244,699	0	492,635	49.7%
2025-07-23	221,784	0	517,973	42.8%
2025-07-22	184,579	787	359,377	51.4%
2025-07-21	203,160	0	367,500	55.3%
2025-07-18	187,790	0	327,248	57.4%

The data here is derived from FINRA daily shorted trade data. The Daily Short Sale Volume is the total volume of short trades that meet certain criteria on each trade date by 6 PM ET on the trade date. The detail trade data is derived from the monthly shorted trade data which will differ in aggregate. The detail trade data is derived from the transaction level data and includes ALL trades (including exempt) and the aggregation period extends beyond 6pm.

Back to Listing

Disclaimer

All information is provided as is without warranty and should be used for indicative purposes only. You should independently check data before making any investment decision. This information is derived from third party sources and we cannot guarantee that their data is current, accurate, complete, free from defects etc and we therefore accept no responsibility for how it may be used. We accept no liability for the reliability or accuracy of the data provided. We are not making recommendations for any financial instruments listed on this website.

Stock Name / Fund	iShares VII PLC - iShares MSCI USA Small Cap ESG Enhanced ETF USD Acc
Issuer	Blackrock
Entity holding fund	iShares VII Public Limited Company
Entity Type	Umbrella investment company with variable capital and having segregated liability between its funds
Entity LEI	549300Q7FFITMZ2PFZ28
ETF Ticker	CUS1(GBX) LSE
ETF Ticker	CUSS(USD) LSE
ETF Ticker	SXRG(EUR) F
ETF Ticker	CSUSS.MI(EUR) CXE
ETF Ticker	CSUSSz(USD) CXE
ETF Ticker	CUSS.LS(USD) CXE
ETF Ticker	CSUSS(EUR) ETF Plus
ETF Ticker	CUS1.L(GBP) LSE
ETF Ticker	CUSS.L(GBP) LSE